and invited him and other captivity survivors to the White House, Sharon Sharabi, Eli's brother, said in an interview with Keshet 12 this morning. Sharabi and other captivity survivors are due to ...
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s ...
That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).
US President Donald Trump has invited released hostage Eli Sharabi to the White House after watching his testimony in Channel 12’s Uvda, Sharabi’s brother, Sharon, told Channel 12 on Sunday.
Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...
President Trump has invited a freed Israeli hostage who suffered barbaric treatment while he was held in Gaza to the White House. Eli Sharabi, who was freed on Saturday February 8 after ...
The U.S. House of Representatives passed a bipartisan bill from Rep. Eli Crane that would require national defense agencies to share with Congress more information about illegal cross-border tunnels.
The image of Israeli hostage Eli Sharabi being released from Gaza a little over two weeks ago, looking gaunt and weak, shocked and angered Israel and leaders around the world. His brother Sharon ...
Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...
Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...
At least $241 million in taxpayer funds was spent on transgender surgeries and animal experiments, prompting a congressional lawmaker to question the rationale behind the expenditures. Rep.